Concepedia

Endocrine Resistance

Endocrine Resistance is a biological phenomenon characterized by the diminished responsiveness of target cells or tissues to steroid hormone signaling, despite the presence of normal or elevated hormone levels, resulting in impaired physiological or therapeutic effects.

461

Publications

31.6K

Citations

3.5K

Authors

975

Institutions

Publications per year

2017–2026

224

Parents

Publications

461

Molecular determinants of resistance to antiandrogen therapy

Charlie D. Chen, Derek S. Welsbie, Chris Tran et al. · Nature Medicine · 2003 · 2.3K citations

, , +17

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

Stephen Johnston, John Pippen, Xavier Pivot et al. · Journal of Clinical Oncology · 2009 · 1K citations · Full text

, , +17

<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Nicholas C. Turner, Alex Pearson, Rachel Sharpe et al. · Cancer Research · 2010 · 738 citations · Full text

, , +17

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study

Thomas Bachelot, C. Bourgier, Claire Cropet et al. · Journal of Clinical Oncology · 2012 · 709 citations · Full text

, , +17

Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer

Nicholas C. Turner, Mafalda Oliveira, Sacha J. Howell et al. · New England Journal of Medicine · 2023 · 704 citations · Full text

, , +16

1–5 of 461

Authors

3.5K

  1. RS
    Rachel Schiff

    Baylor College of Medicine, United States

    14 publications · 2.4K citations

    14

    h-index

  2. MD
    Mitch Dowsett

    Royal Marsden Hospital, United Kingdom

    12 publications · 1.1K citations

    12

    h-index

  3. MJ
    Matthew J. Ellis

    Washington University in St. Louis, United States

    11 publications · 656 citations

    11

    h-index

  4. CK
    C. Kent Osborne

    Baylor College of Medicine, United States

    11 publications · 2.2K citations

    11

    h-index

  5. RJ
    Rinath Jeselsohn

    Dana-Farber Cancer Institute, United States

    11 publications · 1.3K citations

    11

    h-index

1–5 of 3.5K

Institutions

975

  1. Baylor College of Medicine

    Houston, United States

    28 h-index

    194 publications

    23.1K citations

  2. Institute of Cancer Research

    London, United Kingdom

    21 h-index

    130 publications

    24.6K citations

  3. Dana-Farber Cancer Institute

    Boston, United States

    19 h-index

    102 publications

    12.7K citations

  4. The University of Texas MD Anderson Cancer Center

    Houston, United States

    17 h-index

    44 publications

    1.6K citations

  5. Royal Marsden Hospital

    London, United Kingdom

    17 h-index

    62 publications

    16.1K citations

  6. Breast Cancer Now

    London, United Kingdom

    16 h-index

    115 publications

    22K citations

  7. Harvard University

    Cambridge, United States

    15 h-index

    74 publications

    5K citations

  8. Institut Curie

    Paris, France

    12 h-index

    33 publications

    1.8K citations

1–8 of 975

Venues

  1. Clinical Cancer Research

    26 publications · 2.6K citations

    23

    h-index

  2. Breast Cancer Research

    BCR · 26 publications · 1.7K citations

    23

    h-index

  3. Cancer Research

    23 publications · 2.3K citations

    19

    h-index

  4. PLoS ONE

    16 publications · 651 citations

    14

    h-index

  5. Journal of Clinical Oncology

    17 publications · 2.4K citations

    14

    h-index

1–5